The PI3K pathway: clinical inhibition in chronic lymphocytic leukemia
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Reference35 articles.
1. The treatment of relapsed refractory chronic lymphocytic leukemia;Brown;Hematology Am Soc Hematol Educ Program,2011
2. Targeting the B Cell Receptor Pathway in Chronic Lymphocytic Leukemia;Davids;Leuk Lymphoma,2012
3. p110delta, a novel phosphatidylinositol 3-kinase catalytic subunit that associates with p85 and is expressed predominantly in leukocytes;Chantry;J Biol Chem,1997
4. Phosphoinositide 3-kinases: a conserved family of signal transducers;Vanhaesebroeck;Trends Biochem Sci,1997
5. Signalling by PI3K isoforms: insights from gene-targeted mice;Vanhaesebroeck;Trends Biochem Sci,2005
Cited by 35 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The Oral PI3Kδ Inhibitor Linperlisib for the Treatment of Relapsed and/or Refractory Follicular Lymphoma: A Phase II, Single-Arm, Open-Label Clinical Trial;Clinical Cancer Research;2023-02-03
2. Cellular lipids in B cell immunity, inflammation, and cancer;Cellular Lipid in Health and Disease;2023
3. PI3K Inhibitors for the Treatment of Chronic Lymphocytic Leukemia: Current Status and Future Perspectives;Cancers;2022-03-18
4. B-cell antigen receptor expression and phosphatidylinositol 3-kinase signaling regulate genesis and maintenance of mouse chronic lymphocytic leukemia;Haematologica;2022-01-13
5. Membrane-bound SCF and VCAM-1 synergistically regulate the morphology of hematopoietic stem cells;Journal of Cell Biology;2021-08-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3